Defining Inflammatory Markers of Cardiovascular Disease in Patients With Myelodysplastic Syndromes

Conditions

• Myelodysplastic Syndromes, Adult

Eligibility Criteria

Sex

ALL

Age

18 Years - N/A

Healthy Volunteers

Not accepted

Interventions

• Observational — OTHER
  Blood will be collected from one cohort to identify potential blood biomarkers.

Study Details

Why Is This Research Study Being Conducted? * The study wants to find out why people with a type of blood cancer called myelodysplastic syndromes (MDS) are more likely to have heart problems like heart disease and stroke. * Researchers also want to see if certain proteins related to inflammation in the body can help predict these heart issues in MDS patients. * By understanding this better, researchers hope to find new ways to detect and manage heart disease risks in people with MDS

Key Dates

Start date

Nov 5, 2024

Status verified

Feb 2026

Primary completion

Nov 30, 2027

Completion

Nov 30, 2027

Study Design

Enrollment

30 participants (estimated)

Arms

• Arm: Adults with Myelodysplastic syndromes
  All participants will be in one group. Participants will by adults with Myelodysplastic syndromes. Blood will be taken at regular appointments that are part of standard care.

Primary Outcome Measure

Biologic Variability of Markers of Inflammation in the Blood [ Time Frame: over 6 months ]

Central Contacts

• Diego Adrianzen Herrera, MD
  (802) 656-2021
  [email protected]
• Neil A Zakai, MD
  (802) 656-2021
  [email protected]

Locations (1)

Find similar trials in Burlington, VT